{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"ATS Assemblies & Sections","title":"ATS Assembly on Pediatrics Advocacy Series Podcast: Policy Related Advocacy","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/8a3d8e4b\"></iframe>","width":"100%","height":180,"duration":2246,"description":"This is the second episode of our Advocacy Series — a collection of podcasts dedicated to exploring key issues in pediatric pulmonology.\nIn this episode, Robyn Cohen, MD, MPH, and Will Feldman, MD, DPhil, MPH, share their experiences in policy-related advocacy, focusing on inhaler policy, including topics related to Flovent (Fluticasone). They discuss recent developments, challenges, and barriers in inhaler policy, as well as practical tips and strategies for engaging in policy work.\n00:00 – Podcast Opening, Hosts, Topic Setup & Guest Introductions\n02:40 – Early Experiences, Origins of Inhaler Advocacy & Media Attention\n05:00 – Pediatric vs Adult Perspectives, Policy Challenges & Initial Industry/Regulatory Issues\n10:00 – Ongoing Aftermath of Inhaler Discontinuations, Community Impact & System Barriers\n15:00 – Market Forces, Dry-Powder Alternatives, Patents & Device Innovation Limitations\n19:57 - Patent Protection, New Products, and Market Incentives\n22:01 - Environmental Concerns, Formularies, and Clinician Constraints\n24:03 - Recommended Resources and Understanding Patents/PBMs\n26:09 - Advocacy Challenges, Publishing Op-Eds, and Media Engagement\n29:04 - Policy Barriers, Authorized Generics, and Institutional Advocacy Support\nAdditional Resources:\nDr. Feldman’s Testimony regarding  pharmaceutical patents before the Senate Judiciary Committee:\nhttps://www.judiciary.senate.gov/committee-activity/hearings/ensuring-affordable-and-accessible-medications-examining-competition-in-the-prescription-drug-market\nA version of Dr. Feldman’s written testimony:\nhttps://pubmed.ncbi.nlm.nih.gov/40197405/\nLetter in Peds Pulmonology describing the experience of inhaler advocacy:\nhttps://pubmed.ncbi.nlm.nih.gov/40105398/\nCohen RT, Christy Sadreameli S, Coates AC, Nelson BA, O'Sullivan BP; Members of the Advocacy Subcommittee of the American Thoracic Society Pediatrics Assembly and the New England Pediatric Pulmonary Consortium. Ensuring Inhaler Access for Children: A Case Study in...","thumbnail_url":"https://img.transistorcdn.com/9DaPUiuZAWF4aqHRUVM8yVGNq8O1aIe3EajK-tlwSGU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83OTVl/MDQ0ZDc5MGUwMThk/NDZkZjBhNWNmZTNm/NGZmOC5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}